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Abstract 
Background: Methicillin resistant Staphylococcus pseudintermedius (MRSP) and Staphylococcus aureus (MRSA) are 
common multi‑drug resistant (MDR) bacteria in dogs. In 2012–2013 three dogs of the Guide Dog School of the Finn‑
ish Federation of the Visually Impaired were found to be MRSP positive. Guide dogs have regular contact with each 
other during their first year of life and prolonged contact when in training. Since dogs are placed in different parts 
of Finland after training, there is a risk for national spread of MDR bacteria. In this study the prevalence of MRSP and 
MRSA, as well as the risk factors for MRSP were determined in the Finnish guide dog population. MRSP isolates were 
investigated using molecular methods and compared to the earlier isolates.
Results: Out of 132 tested dogs 4 were MRSP positive thus giving the prevalence estimate of 3% (95% CI: 1–8%) for 
MRSP in the target population. MRSA was not detected (prevalence estimate 0%, 95% CI: 0–3%). Risk factors associ‑
ated with MRSP were being a breeding bitch (OR = 8.4; 95% CI: 1.1–64.1, P = 0.012), the number of veterinary visits 
(OR = 1.23; 95% CI: 1.0–1.5, P = 0.025) and number of antimicrobial courses (OR = 1.63; 95% CI: 1.0–2.55; P = 0.035). 
Identified MRSP isolates belonged to five different sequence types (ST45, 71, 402, 403 and 404). All ST71 isolates 
carried SCCmec II‑III, while the SCCmec type of the ST45 and ST402 (a single locus variant of ST45) isolates were non‑
typeable with the method used.
Conclusions: MRSP and MRSA had low prevalence in the studied dog population despite the close contact between 
dogs, and the MRSP population was heterogenic. Antimicrobial therapy and veterinary visits are risk factors for MRSP 
even among a small case group.
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Background
Staphylococcus pseudintermedius belongs to the normal 
microbiota of dogs and is an opportunistic pathogen [1]. 
The bacterium can cause a plethora of infections in dogs 
and is also capable of causing infections in humans [2]. 
Since the mid 2000’s methicillin resistant S. pseudinter-
medius (MRSP) isolates have become more common [3, 
4]. This has raised concern of emerging antimicrobial 
resistance and infections that are difficult to cure with 
available antimicrobials [2]. MRSP has spread clon-
ally in Europe and North America [5]. The predominant 
European clone, ST71(MLST)-t02(spa)-II-III(SCCmec), 
has been determined to be the principal MRSP clone in 
Sweden [6] and has also been observed in Finland, where 
it caused a large outbreak in a veterinary teaching hos-
pital [7]. Of other staphylococci, Staphylococcus aureus 
is a common human pathogen, but is less prevalent in 
dogs [8]. Nevertheless, methicillin resistant S. aureus 
(MRSA), traditionally a nosocomial pathogen of humans, 
is also found in dogs and can cause infections in them 
[9]. MRSA may also be more readily transmitted between 
dogs and owners than MRSP [10, 11].
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The Guide Dog School of the Finnish Federation of 
the Visually Impaired provides guide dogs to the blind 
and visually impaired in Finland. In 2012–2013, MRSP 
was found in routine clinical specimens of three guide 
dogs, all suffering from atopic dermatitis. The dogs of the 
Guide Dog School constitute a special group of animals; 
they are in close contact during training at the Guide Dog 
School kennel, after which they are sent all over the coun-
try. During their service years, they also regularly visit 
the school’s premises. Thus nationwide risk for spread of 
resistant bacteria is a valid concern. Due to these factors 
it was decided that the epidemiology of MRSP and MRSA 
needed to be determined in this population. The present 
study was conducted (1) to establish the prevalence of 
MRSP and MRSA in the Finnish guide dog population, 
(2) to genotype and compare isolates from the Guide Dog 
School’s dog population and (3) to detect risk factors for 
carriage of MRSP.
Methods
This study consisted of four parts; (1) a cross-sectional 
prevalence study of MRSP/A in the guide dog popula-
tion as well as a case–control study to determine the risk 
factors for MRSP/A, (2) the screening of contact dogs 
of MRSP positive dogs from the prevalence study, along 
with extended screening of breeding bitches of the Guide 
Dog School and (3) the comparison of the MRSP isolates 
from these dogs. The fourth part of the study included 
mapping of possible transmission routes as well as longi-
tudinal follow-up of the MRSP-status of four dogs.
The prevalence and risk factor study
The guide dog population
The Guide Dog School (GDS) of the Finnish Federa-
tion of the Visually Impaired is situated in the greater 
Helsinki area in Finland [12]. The school is a nonprofit 
organization whose mission is to enhance the inde-
pendence of people who are blind or visually impaired 
through the use of specially trained dogs. The school 
breeds the majority of their dogs themselves. Breeding 
bitches are housed in volunteer families. The bitches give 
birth at the school’s facilities in a separate ward reserved 
for this purpose. Puppies spend their first 6 weeks with 
their dam at the school after which they are weaned and 
housed in volunteer families. During the first year of 
their life the dogs have regular (short) appointments at 
the school. At the age of 13–18 months guide dog can-
didates are transferred back to the school where they 
undergo suitability testing. If selected, the dog begins a 
training period of 20  weeks after which it is placed for 
service as a guide dog. During their service the dogs 
spend short periods at the school in training; the GDS’s 
facilities also serve as a kennel to guide dogs during 
vacations of their host/hostess. At the time the study 
was planned, the size of the guide dog population was 
approximately 330 dogs. Out of these roughly 110 dogs 
were in training, 200 worked as guide dogs and 20 ani-
mals were breeding bitches.
Sample size calculation
Sample size for the entire 330 dog population was calcu-
lated using EpiTools [13]. The estimated sample size was 
152 dogs with an approximated MRSP prevalence of 3% 
with a ±2% desired precision on a 95% confidence level. 
The occurrence of MRSP varies significantly between 
studies depending on used methods, population and 
geographical origin. Figures between zero and 42 per-
cent have been reported [14–21]. The guide dogs were 
considered a low risk population, thus the three percent 
estimate was based on studies that were assessed to rep-
resent our target population. These showed a prevalence 
between 1.5 and 4.5 percent [15–17, 20, 21]. The calcu-
lation of sample size for MRSA separately was not con-
sidered necessary, since the prevalence of MRSA was 
expected to be less than that of MRSP.
Specimens and data collection
Specimens for the prevalence study were collected 
between February and November 2014 when the dogs 
visited the GDS. This method was selected out of con-
venience instead of random sampling. Three to four sites 
of each dog were swabbed by using sterile cotton tips 
(M40 Transsystem Amies Agar Gel without charcoal, 
Copan Diagnostics Inc., Italy): the first swab was taken 
from the mucous membranes of the anterior nares and 
mouth (combined swab), the second swab from the per-
ineal area, and the third from skin abrasions/wounds if 
present. The specimens were then transferred to the 
Clinical Microbiology Laboratory at the Faculty of Vet-
erinary Medicine of the University of Helsinki. In the 
laboratory the specimens were kept refrigerated at 4°C 
if they arrived outside office hours. All specimens were 
processed within 2 days of sampling.
To determine the representativeness of the sample pop-
ulation to the target population, the age, sex, breed and 
dog group variables as well as the exact number of dogs 
in the whole population and different subgroups were 
collected from the entire target population. To identify 
possible risk factors for MRSP, the following data were 
collected from the dogs of the sample population: breed, 
sex, age, whether the animal was bred by the GDS or pur-
chased, whether it was a trainee, at service or a breed-
ing bitch, and medical history. Medical history included 
information on previous skin disease, antimicrobial and 
other medical treatments within a 12 month period prior 
to entering the study.
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Data analysis
The prevalence estimates for MRSP and MRSA were cal-
culated by number of positive specimens divided by total 
number of collected specimens and presented as per-
centages. The 95% confidence intervals (95% CI) for the 
prevalence estimates were determined using an EpiTools 
calculator [22]. Confidence intervals were reported based 
on the Wilson score interval due to the low prevalence 
[23]. The representativeness of the sample population 
was assessed by using the Fisher’s exact test for sex, breed 
and dog group, and using an independent two-sample t 
test for age.
Descriptive statistics of the study variables were calcu-
lated by MRSP status. To identify risk-factors, the asso-
ciations of the studied variables (see “Specimen and data 
collection”) with a positive MRSP result were evaluated 
with univariable logistic regression models. Due to very 
few positive MRSP results in the data, the rareness of the 
events was taken into account in the modelling by apply-
ing Firth’s bias adjustment method [24], which maximizes 
a penalized likelihood function, instead of the standard 
maximum likelihood function. Odds ratios (OR) with 
95% profile likelihood [25] confidence intervals (CI) were 
calculated to quantify the results. P values ≤0.05 were 
considered statistically significant. All statistical analyses 
were done using SAS® System for Windows, version 9.3 
(SAS Institute Inc., Cary, NC, USA).
Specimens from contact dogs and breeding bitches
Three contact dogs of MRSP positive guide dogs were 
screened for MRSP. Because two breeding bitches were 
observed to be MRSP-positive in the prevalence study, 
MRSP screening was extended to the rest of dogs of that 
subpopulation (n  =  5). The same technique as for the 
prevalence study was used when taking these specimens.
Mapping of transmission routes, and follow‑up specimens
Information on possible transmission routes was 
obtained by questioning the caregiver of the dogs as well 
as from event logs of the guide dog school. The MRSP 
statuses of four dogs were followed for over 6  months. 
Specimens were collected as described above. MRSP 
decolonization therapy using chlorhexidine washes and/
or topical application of fusidic acid to mucous mem-
branes was attempted in three of these dogs.
Bacteriological analyses
Culture, identification and susceptibility testing
Specimens from the same dog were pooled into an 
enrichment broth (Tryptic Soy Broth supplemented 
with 6.5% NaCl, Tammer-Tutkan Maljat, Finland) and 
incubated for 16–22  h at +35.0°C. Then an aliquot of 
the broth was plated onto a selective agar plate (MRSA 
Select, BioRad, USA). Plates were incubated up to 48  h 
at +35.0°C and were inspected daily. Species identifica-
tion was done by conventional means; as described by 
Grönthal et al. [7]
Antimicrobial susceptibility was tested by the CLSI 
disk diffusion method to the following antimicrobials: 
oxacillin, erythromycin, clindamycin, tetracycline, sul-
famethoxazole-trimethoprim, fusidic acid, enrofloxacin, 
gentamicin and amikacin [26, 27]. SIR categories were 
assigned based on the breakpoints of the CLSI standard, 
except for fusidic acid, for which breakpoints of ≥24 mm 
(susceptible) and ≤18  mm (resistant) were used [28]. 
Staphylococcus aureus ATCC 25923 was used as a quality 
control strain for susceptibility testing.
Molecular typing of the MRSP isolates
Molecular typing was performed for MRSP isolates 
detected in the prevalence study, MRSP isolates of the 
contact dogs and for previous MRSP isolates from the 
guide dogs.
To detect clonal clusters, mecA-positive isolates were 
typed using pulsed-field gel electrophoresis (PFGE) [29] 
with modifications [7]. All isolates were analyzed with 
both SmaI and AscI restriction enzymes. DNA frag-
ments were separated on 1% agarose by using a Chef DR 
III system (Bio-Rad, USA). The total run time was 22 h; 
the first-block switch time was 0.1–15 s for 15 h, and the 
second-block switch time was 15–60 s for 7 h. The volt-
age for the run was 6  V/cm with an included angle of 
120°. PFGE patterns were analyzed using Gel Compar II 
software (version 6.6, Applied Maths, Belgium). UPGMA 
based cluster analysis with the Dice similarity coefficient 
was used with optimization and position tolerance both 
set at 1%. Isolates were clustered using an 85% similarity 
cut-off.
DNA for mecA-PCR, SCCmec and MLST-typing was 
extracted using a commercial kit (InstaGene Matrix, 
Bio-Rad, USA) as previously described [30]. Oxacillin 
resistant S. pseudintermedius isolates were confirmed to 
carry the mecA-gene using PCR-primers (mecA P4 and 
mecA P7) described by Stegger et al. [31]. Both primers 
had a concentration of 0.25  µM in a final reaction vol-
ume of 20  µl. The PCR was performed with a BioRad 
CFX96 Real-Time PCR detection system using SsoAd-
vanced Universal SYBR Green Supermix (Bio-Rad, USA) 
with initial denaturation at 98.0°C for 2 min, followed by 
40 cycles of denaturation (98.0°C for 5 s) and annealing/
elongation (60.0°C for 45  s). Finally a denaturation step 
(98.0°C for 5 s) preceded the melt-curve analysis (65.0°C 
to 95.0°C in 0.5°C increments) that was used to verify the 
product. The product had a melting point of 77.5–78.0°C. 
Staphylococcus aureus ATCC 43300 was used as a posi-
tive control for mecA-testing.
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The SCCmec cassettes were typed using a previously 
described multiplex PCR-method [32] with the follow-
ing modifications: In M-PCR-1 primers γR and γF had 
a final concentration of 0.3  µM, while all other primers 
in M-PCR-1 and M-PCR-2 had a final concentration of 
0.2  µM. The PCRs were performed with Phire Green 
HotStart II DNA polymerase (Thermo Scientific, USA) 
with 200  µM of each dNTP in a reaction. The condi-
tions for the PCRs were as follows: Initial denaturation at 
98.0°C for 1  min, followed by 40 cycles of denaturation 
(98.0°C for 15  s), annealing (56.0°C for 10  s) and elon-
gation (72.0°C for 45 s), and a final elongation for 2 min 
at 72.0°C. Bands were visualized using SYBR Safe DNA 
stain (Life Technologies, USA) after electrophoresis in a 
1% agarose.
MLST typing was performed according to the method 
described by Solyman et al. [33] with modifications: Phu-
sion Flash High-Fidelity PCR Master Mix (Thermo Sci-
entific, USA) was used for the reaction; the tuf-primers 
had a final concentration of 0.375  µM each, while all 
other primers had a concentration of 0.25 µM. The PCR-
protocol consisted of a 15 s initial denaturation at 98°C, 
30 cycles of denaturation (98°C for 2 s), annealing (52°C 
for 10 s) and elongation (72°C for 15 s), with final exten-
sion for 1  min at 72°C. Each PCR-product was purified 
using Exonuclease I (Thermo Scientific, USA) and FastAP 
thermosensitive alkaline phosphatase (Thermo Scientific, 
USA) according to the manufacturer’s instructions. The 
sequencing for MLST was performed at a commercial 
laboratory (Macrogen Inc., Netherlands) with an ABI 
3730 XL automated sequencer. The sequences were ana-
lyzed using the CLC Main Workbench (version 6.9.1, 
CLC bio, Denmark) with CLC MLST module (version 
1.4.7, CLC bio, Denmark) comparing sequences of the 
housekeeping genes to the S. pseudintermedius MLST 
database [34].
Results
Prevalence and risk factor study
Specimens were taken from 132 dogs of which four 
were MRSP-positive (prevalence estimate for the pop-
ulation 3%, 95% CI: 1–8%). None of the screened dogs 
were positive for MRSA (prevalence estimate 0%, 95% 
CI: 0–3%). The breed and sex of the sample population 
was representative to the target population, while dog 
groups and age differed to that of the target population 
(Table 1).
Skin or ear disease history was reported in 49% of the 
dogs (range 43–55%; lowest in trainees, highest in guide 
dogs) and antimicrobial treatment in 52% of the dogs 
(range 43–60%; lowest in guide dogs, highest in trainees). 
Logistic regression analyses revealed three risk factors; 
(1) being a breeding bitch, (2) the number of antimicro-
bial courses received and (3) the number of veterinary 
visits. Results from logistic regression are presented in 
Table 2.
Screening of contact dogs and breeding bitches
Three contact dogs were screened of which two were 
MRSP positive. These both (dogs P-853 and 2014-887) 
were living together with the guide dog P-833. The con-
tact P-853 gave a negative result in the first screening, but 
was observed to be MRSP positive in the second screen-
ing a month later (Figure  1). Extended screening of the 
Table 1 Comparison of  demographics in  the target and  sample populations of  the Finnish Guide Dog School’s dogs 
in this study
* Percent values are rounded.
Sample population Target population Statistical difference
n = 132 %* n = 308 %* P‑value (method)
Sex 0.92 (Fisher’s Exact test)
 Male 65 49 158 51
 Female 67 51 150 49
Breed 0.84 (Fisher’s Exact test)
 Labrador retriever 124 94 287 93
 Other 8 6 21 7
Dog group 0.01 (Fisher’s Exact test)
 Guide dog 56 42 187 61
 Dog in training 68 52 103 33
 Breeding dog 8 6 18 6
Age Mean (min–max) Median Mean (min–max) Median 0.03 (t test)
3.8 (0.2–13.9) 2.1 4.6 (0.2–13.9) 3.9
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rest of the breeding bitches (n = 5) revealed no cases of 
MRSP.
Comparison of MRSP isolates
Characteristics of the nine MRSP isolates are compared 
in Figure 2: four were from the prevalence study (P-833, 
P-834, P-843 and P-860), two (P-853 and 2014-887) were 
from contact dogs of the guide dog P-833 and three were 
isolates that had been preserved in 2012–2013 from other 
guide dogs (P-495, P-527 and P-781). All but one isolate 
(P-781) were multiresistant (resistant to ≥3 antimicrobial 
groups). The MRSP isolate of a contact dog 2014-887 
shared an identical antibiogram with the MRSP of the 
guide dog P-833, but the other contact’s isolate (P-853) 
differed from these (Figure 2).
All, except the isolate 2014-887, were available for 
molecular typing. Of the four isolates from the prev-
alence study, three (P-833, P-843 and P-860) were 
non-typeable by SmaI restriction but gave identical AscI-
restriction profiles (Additional file  2). Both SmaI and 
AscI restriction patterns indicated that the other five iso-
lates were not closely related (Figure 2; Additional File 2).
Table 2 Risk factors associated with MRSP in the Finnish Guide Dog School population in 2014
* For the past 12 months. CI confidence interval using Firth’s bias adjustment (see text) and OR odds ratio.
MRSP‑pos (n = 4) MRSP‑neg (n = 128) Univariable logistic regression
Categorical variables n % n % Unadjusted OR (95% CI) Likelihood P
Demographics
 Gender: F vs.M 3 75.0 62 48.4 2.48 (0.40–26.13) 0.338
 Breed (labrador retriever vs. other) 4 100.0 120 93.8 0.64 (0.06–86.75) 0.779
 Dog bought vs. bred by school 0 0.0 13 10.2 0.95 (0.01–9.70) 0.973
 Dog group
  Breeding vs. training 2 50.0 6 4.7 8.39 (1.12–64.13) 0.012
  Training vs. working 0 0.0 68 53.1 0.16 (0.00–2.01)
Epidemiological data
 History of ear or skin disease 1 25.0 63 52.1 0.40 (0.04–2.48) 0.328
 Antimicrobial treatment* 3 75.0 66 52.8 2.09 (0.33–21.99) 0.441
Continuous variables n Mean n Mean Unadjusted OR (95% CI) Likelihood P
Demographics
 Age 4 5.8 128 3.8 1.18 (0.92–1.49) 0.185
Epidemiological data
 Number of veterinary visits* 4 9.8 128 4.9 1.23 (1.030–1.48) 0.025
 Number of antimicrobial courses* 4 2.8 126 1.0 1.63 (1.04–2.55) 0.035
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The four MRSP-isolates from the prevalence study rep-
resented three different sequence types (Figure  2). Two 
were of ST45, while ST71 and ST402 had one representa-
tive each. The ST402 strain was a single locus variant of 
ST45: it had an A166 to G substitution in the purA 2 allele 
sequence compared to ST45. The new purA allele num-
ber was 40 [34]. The isolate from dog P-781 was assigned 
a new sequence type (ST403) being closest to ST41, with 
a different cpn60 allele type (13 instead of 25). The isolate 
from dog P-495 was closest to ST150, but had a differ-
ent fdh allele type (4 instead of 1) and a G6 to A substi-
tution in the sar 1 allele (assigned sar allele number 17). 
This isolate was designated sequence type ST404 [34]. 
Isolates belonging to ST71 harbored SCCmec II-III. The 
ST45 and ST402 isolates were non-typeable by the SCC-
mec method used, as only the mecA-gene was amplified 
in M-PCR-1. Isolate P-781 that belonged to ST403 gave 
an unusual result in the SCCmec analysis as it seemed 
products specific to gene allele’s ccrA2 and ccrA4 were 
amplified in M-PCR-1 (Additional file 1).
Investigation of transmission routes
Transmission route investigation revealed that dogs 
P-843 and P-860 had been in direct contact at the GDS. 
Also, dogs 2014-887 and P-853 lived in the same family 
as dog P-833. A member of this family worked at a small 
animal practice, where the dogs had visited. No other 
apparent temporal or spatial connections between the 
dogs were found.
Follow‑up specimens
Samples were collected from four MRSP positive dogs. 
MRSP decolonization therapy was performed on three 
dogs of which two were guide dogs (P-833 and P-844) 
and one was a contact of the guide dog P-833. The other 
contact of dog P-833 was euthanized due to severe ill-
ness. The dogs were followed for over 6  months, with 
four to seven samples taken roughly 2 weeks to 3 months 
apart. The timing and results of the follow-up samples 
are presented in Figure 1.
Discussion
The prevalence of MRSP was determined to be 3% in the 
Finnish Guide dog population, matching the predicted 
prevalence. No MRSA positive dogs were discovered, 
but the true prevalence lies somewhere between 0 and 
3%. There are some study limitations to consider. As seen 
in Table 1, dogs in training were overrepresented at the 
expense of guide dogs. This discrepancy is explainable 
by ease of access, as dogs in training were more readily 
available for sampling at the GDS. This is also a reason to 
the difference in age, since dogs in training are younger 
than other dogs. The sample population represented the 
target population well as for breed and sex, and the tar-
geted sample size (152) was close to the obtained (132). 
The fact that the sample population was slightly skewed 
could have impacted the results of the study. Also, as pre-
viously reported [7], the screening method used in this 
study has a limit of detection of ~10 colony forming units 
for MRSP with a oxacillin minimum inhibitory concen-
tration (MIC) ≥4  µg/ml. Therefore, using this method, 
MRSPs with very low oxacillin MIC may be missed, and 
thus the prevalence may be slightly underestimated. As 
this was a known problem, pure cultures were readily 
taken from selective plates upon the slightest indication 
of a suspected colony. In our experience this has yielded 
many carriers with MRSP-isolates having low oxacillin-
MIC (2  µg/ml). In this study a large portion (49%) of 
the sampled dogs did have a history of skin or ear dis-
ease which is a well-known risk factor for MRSP [7, 35]. 
This potentially increased the likelihood for the presence 
of MRSP/A carriers in the population and subsequently 
compensated possible underestimation of the prevalence 
caused by our screening method. In all, the discrepan-
cies in representativeness and methodology were in our 
opinion fairly minor and did not significantly impact the 
result of the study.
Published studies for the prevalence of MRSP or MRSA 
in Finnish dogs are not available. However, to give some 
contrast; there were 581 MRSP/A screening specimens 
investigated in our laboratory in 2014. MRSP was found 
Figure 2 SmaI dendogram and antibiograms of the MRSP‑isolates investigated in the Finnish Guide Dog School MRSP study. Dogs P‑833, P‑853 
and 2014‑887 lived in the same household. OX oxacillin, E erythromycin, DA clindamycin, SXT sulphamethoxazole/trimethoprim, TE tetracycline, FD 
fucidic acid, ENR enrofloxacin, CN gentamicin, AK amikacin, R resistant, S susceptible, NT non‑typeable and NA not analyzed. Unk the result from the 
SCCmec analysis of isolate P‑781 was inconclusive (see text and Additional file 1). The grey dashed line indicates the 85% cut‑off value.
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in 56 of these (9.6%) while MRSA was only found in 5 
specimens (0.9%). It is important to note that these speci-
mens were taken from dogs with identifiable risk factors 
or patients that had been exposed to MRSP or MRSA. 
Only a few studies exist that have measured the preva-
lence of MRSP among specific animal groups. In a study 
of shelter animals by Gingrich et  al. [15] in Colorado, 
USA, the prevalence of MRSP in dogs was 3%, while the 
prevalence of MRSA in dogs was 0.5%. These numbers 
coincide quite well with our study. In Slovenia, the preva-
lence of MRSP (then MRSI) was 1.5% (3/200) in clinically 
healthy dogs in a community, while MRSA was not dis-
covered [20]. Regarding veterinary hospitals, Hanselman 
et  al. [21] reported a MRSP prevalence of 2.1% and 
MRSA prevalence of 0.5% in dogs upon admission in 
Ontario, Canada. A similar study conducted in Hanno-
ver, Germany reported a higher MRSP prevalence (7.4%) 
[36]. Further, Boost et al. [8] investigated the prevalence 
of S. aureus in dogs and their owners in Hong Kong. 
They found an MRSA prevalence of 0.7% among the dogs 
investigated, which falls into the 0-3% prevalence esti-
mate in our study and corresponds well to our laboratory 
data. Further study is however needed to ascertain the 
prevalence of MRSP and MRSA in the average dog popu-
lation as well as subpopulations, to identify target groups 
for preventive measures.
In this study, a dog had a higher risk for MRSP if it was 
a breeding bitch or had a greater number of antibiotic 
courses or veterinary visits, but due to the low number 
of MRSP positive cases our results are only supportive at 
best. The fact that being a breeding bitch was significant 
in the risk factor analysis is likely a coincidence due to the 
low number of dogs in this group. As Figure 1 indicates, 
one of the MRSP positive breeding bitches (P-860) was 
only a transient carrier and had likely caught it through 
contact to another MRSP positive dog (P-843). Extended 
screening of the breeding bitches did not reveal any new 
MRSP cases, indicating that it is not a problem among 
these dogs. It would however be preferable if breeding 
bitches would remain MRSP negative to avoid the trans-
fer of these bacteria to new generations of guide dogs. 
Further, there are apparent dependencies between some 
risk factors: for example, dogs with multiple antimicro-
bial courses have visited a veterinarian more often. Con-
trolling of these types of confounders with multivariable 
modelling was not possible in our study due to very small 
number of MRSP positive dogs. Thus far, there is however 
compelling evidence to suggest that antimicrobial therapy 
is a major risk factor for acquiring MRSP/A [7, 36, 37]. 
Other, previously identified, risk factors for MRSP include 
hospitalization [35, 36] and repeated veterinary visits [35, 
36]. Glucocorticoid therapy has also been implicated as a 
risk factor for MRSP by some studies [35, 36].
A considerable number (52%) of dogs in this study 
had received antimicrobial therapy in the twelve months 
prior to the study. Such a large portion of animals receiv-
ing antimicrobials is concerning. Much of the use is 
likely explained by the large proportion (49%) of dogs 
having history of skin or ear disease of some sort. Labra-
dor retrievers, which constitute the vast majority of the 
guide dog population, are known to be predisposed to 
atopy [38], which exposes them to skin and ear infections 
and subsequent use of antimicrobials. National, species 
specific antimicrobial consumption data are not readily 
available for Finland. In Sweden however, such data has 
been published in the SVARM report [39]. The amount 
of oral antimicrobials prescribed per dog corresponded 
to 563 packages per 1000 dogs in 2009 in Sweden. While 
many dogs likely received multiple packages that year, the 
number is still indicative of a high rate of antimicrobial 
use, comparable to our data. [39]. The use of antimicrobi-
als in dogs could be reduced by prioritizing a healthy skin 
in breeding choices, which is already part of the GDS’s 
breeding program.
The MRSP isolates of this study were rather heteroge-
neous. For example; the isolates belonging to the same 
clonal lineage, ST71, had different PFGE and antibiogram 
profiles. This suggests different sources of contagion, 
possibly outside of the guide dog population. This was 
somewhat surprising, considering the potential for clonal 
spread in a kennel environment. It is possible that the 
MRSP population in Finland is becoming more hetero-
geneous, perhaps due to a decrease in ST71 occurrence, 
as has been seen in Sweden [39]. Only two of the dogs 
(P-843 and P-860) were reported to have been in contact 
with each other. They both carried ST45 with identical 
antibiogram and AscI PFGE-pulsotype. ST71 and ST45 
have previously been found in Finland [7], but three new 
sequence types (STs 402, 403 and 404) were discovered 
in this study (Figure 2). The ST403 had a very surprising 
antibiogram, being resistant only to oxacillin and fusidic 
acid. In our experience such MRSP isolates are very rare. 
Osland et  al. [40] described MRSP isolates with a simi-
lar antibiogram that belonged to ST127. This clone dif-
fers in four out of seven MLST loci from our ST403 [34] 
suggesting a lack of any clonal relationship. Also, the 
variability of the antibiograms in the ST71 isolates was 
novel, as one of the three isolates displayed resistance 
to all antimicrobials but aminoglycosides, while others 
were susceptible to tetracycline and fusidic acid and ami-
kacin, but resistant to gentamicin. Antibiograms of the 
ST71 isolates of this study also differed from the ST71 
strain causing our veterinary teaching hospital outbreak 
[7]. The outbreak strain was susceptible only to amika-
cin and fucidic acid. Based on our unpublished observa-
tions, this study, and a previous one by Grönthal et al. [7], 
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ST45 seems to be a noteworthy MRSP-clone in Finland. 
However, ST45 is not commonly reported in neighbor-
ing countries, such as Sweden [6] or Norway [40], nor 
has it been purported as a major clone on a more global 
scale [5]. It has however been reported as a major clone 
in Thailand and Israel [41].
MRSP isolates that are not typeable by SmaI PFGE and 
SCCmec, have been described in the Netherlands [42], 
Thailand and Israel [41], and Australia [43]. The isolates 
that were non-typeable by SCCmec in the study by Laar-
hoven et al. [42] belonged to MRSP STs 29, 111, 131 and 
143, while only ST29 was non-typeable by SmaI PFGE. 
The allelic profiles of these differ from that of ST45. The 
ST45 and other STs belonging to the clonal complex 
CC45 harbor a pseudo SCCmec element (ΨSCCmec57395) 
described by Perreten et  al. [41]. The ST45 and ST402 
MRSPs isolated in this study will be investigated further 
in the future to confirm the presence or absence of the 
pseudo SCCmec element.
Based on the results form PFGE, MLST and SCCmec 
analyses, as well as transmission route investigation it 
seems clear that dogs P-843 and P-860 carried the same 
MRSP-type. Dog P-833, whose MRSP isolate belonged to 
ST402 had two contact dogs; P-853 and 2014-887. While 
the MRSP isolate for dog 2014-887 was not available for 
further study, it did display an identical antibiogram with 
isolates belonging to ST45/402 indicating that the iso-
late also belongs to one of these sequence types. MRSP 
isolates from the same household are usually similar [10] 
but some diversity among household pets does occur 
[42]. The latter was also seen in our results as dog P-853 
had a different sequence type; ST71. It is possible that 
these dogs have acquired MRSP from a veterinary clinic 
where a family member worked. These dogs did not have 
apparent risk factors for MRSP carriage.
The results of the follow-up samples varied. Dog P-860, 
who had been exposed to the long term carrier P-843, 
was likely a transient carrier or perhaps even it was a case 
of contamination, as no positive samples were detected 
during follow-up. Windahl et  al. [44] investigated the 
length of MRSP carriage and the factors that impacted 
this. Their results indicated that the median length of 
MRSP carriage is 11  months after clinically apparent 
infection, but that antimicrobial therapy with a drug to 
which the bacterium was resistant prolonged carriage 
time. The study used a cut off value of two consecutive 
MRSP-negative specimens to determine the dog was 
MRSP free. However, a longitudinal study of MRSP in 
households found that the results from MRSP screening 
varied in the individual dog [42]. This was also the case 
in our study, as recurrent findings of MRSP in dogs that 
previously had two MRSP negative specimens (P-843 
and P-853) were observed. It is noteworthy however that 
decolonization therapy was attempted in these cases. 
This may have altered the dynamics of the dogs’ microbi-
ome causing unpredictable results. Saijonmaa-Koulumies 
et  al. [45] studied the use of fusidic acid as a means to 
reduce the number of S. pseudintermedius (then S. inter-
medius) on mucous membranes of dogs. They found that 
while therapy did reduce the number of bacteria, the 
effect was only temporary. It would seem logical to think 
that MRSP behaved in the same fashion. S. pseudinter-
medius can however be a bacterium difficult to eradicate 
from dogs, as it is part of the normal microbiota and is 
carried by a majority of dogs [1]. The use of decoloniza-
tion therapy for MRSP is a subject of further study.
Based on our findings it seems that neither MRSA 
nor MRSP are a major concern in the GDS. The stand-
ard hygiene practices likely contribute to the low preva-
lence of MRSA and MRSP at the GDS’s kennels as they 
are likely higher than in most animal shelters. Also, the 
GDS’s kennels do not suffer from many problems one 
could see in rescue kennels, such as overcrowding or 
severely ill animals [46]. It is however still advised that 
the GDS should routinely screen dogs with identifiable 
risk factors, such as skin or ear problems, or dogs that 
receive a lot of antimicrobials.
Conclusions
MRSP and MRSA have low prevalence and are not major 
problems among guide dogs in Finland. The MRSP popu-
lation in these dogs is epidemiologically heterogeneous 
and there is little evidence of clonal spread. The number 
of antimicrobial courses and veterinary visits are iden-
tifiable risk factors for MRSP even in a low prevalence 
canine population.
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